Cameron Howard Flayer, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sensory Receptor Cells | 4 | 2024 | 513 | 1.470 |
Why?
|
| Hypersensitivity | 5 | 2024 | 1171 | 1.400 |
Why?
|
| Ozone | 5 | 2021 | 483 | 1.320 |
Why?
|
| Interleukin-3 | 1 | 2024 | 425 | 0.860 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2024 | 347 | 0.820 |
Why?
|
| Pruritus | 1 | 2024 | 380 | 0.730 |
Why?
|
| Sunburn | 1 | 2021 | 156 | 0.700 |
Why?
|
| Butylene Glycols | 1 | 2019 | 11 | 0.690 |
Why?
|
| Budesonide | 1 | 2019 | 157 | 0.620 |
Why?
|
| Aspergillus fumigatus | 1 | 2019 | 157 | 0.610 |
Why?
|
| Immunity, Mucosal | 2 | 2020 | 483 | 0.590 |
Why?
|
| Allergens | 5 | 2024 | 1432 | 0.560 |
Why?
|
| Enteric Nervous System | 1 | 2020 | 212 | 0.550 |
Why?
|
| Asthma | 6 | 2021 | 6234 | 0.530 |
Why?
|
| Neuropeptides | 1 | 2021 | 944 | 0.520 |
Why?
|
| Interleukin-23 | 1 | 2017 | 201 | 0.520 |
Why?
|
| Glucosides | 1 | 2019 | 512 | 0.480 |
Why?
|
| Glucocorticoids | 3 | 2021 | 2161 | 0.480 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 3 | 2019 | 48 | 0.450 |
Why?
|
| Multigene Family | 1 | 2017 | 1076 | 0.450 |
Why?
|
| Th2 Cells | 2 | 2019 | 1060 | 0.420 |
Why?
|
| Drug Resistance | 2 | 2021 | 1596 | 0.410 |
Why?
|
| Antioxidants | 1 | 2019 | 1668 | 0.380 |
Why?
|
| Th17 Cells | 1 | 2017 | 794 | 0.360 |
Why?
|
| Wound Healing | 1 | 2021 | 2805 | 0.350 |
Why?
|
| Dendritic Cells | 4 | 2021 | 2747 | 0.310 |
Why?
|
| Inflammation | 4 | 2021 | 10773 | 0.300 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3204 | 0.260 |
Why?
|
| Eosinophils | 2 | 2019 | 950 | 0.220 |
Why?
|
| STAT5 Transcription Factor | 1 | 2024 | 265 | 0.220 |
Why?
|
| Vitamin D | 1 | 2017 | 3303 | 0.220 |
Why?
|
| Oxidants, Photochemical | 2 | 2019 | 76 | 0.200 |
Why?
|
| Epidermis | 1 | 2024 | 528 | 0.190 |
Why?
|
| Lung | 2 | 2019 | 10002 | 0.190 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 560 | 0.190 |
Why?
|
| Steel | 1 | 2020 | 27 | 0.180 |
Why?
|
| Chemokine CCL11 | 1 | 2019 | 128 | 0.170 |
Why?
|
| Diacylglycerol Kinase | 1 | 2019 | 46 | 0.170 |
Why?
|
| Decision Trees | 1 | 2021 | 504 | 0.170 |
Why?
|
| Substance P | 1 | 2020 | 335 | 0.170 |
Why?
|
| Immunity, Innate | 2 | 2021 | 3066 | 0.160 |
Why?
|
| Skin | 2 | 2024 | 4484 | 0.160 |
Why?
|
| Oxidative Stress | 2 | 2021 | 3113 | 0.150 |
Why?
|
| Interleukin-18 | 1 | 2020 | 250 | 0.150 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2019 | 273 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 1787 | 0.140 |
Why?
|
| Respiratory System | 1 | 2021 | 563 | 0.140 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 755 | 0.140 |
Why?
|
| Interleukin-13 | 1 | 2019 | 392 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1157 | 0.130 |
Why?
|
| Immune System | 1 | 2021 | 796 | 0.130 |
Why?
|
| Interleukin-10 | 1 | 2021 | 1175 | 0.130 |
Why?
|
| Immunity | 1 | 2021 | 996 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2019 | 823 | 0.120 |
Why?
|
| Animals | 10 | 2024 | 168467 | 0.120 |
Why?
|
| Cytokines | 2 | 2021 | 7396 | 0.120 |
Why?
|
| Fibrosis | 1 | 2021 | 2049 | 0.110 |
Why?
|
| Macaca mulatta | 1 | 2019 | 2329 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 662 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2017 | 1036 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2024 | 23447 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6214 | 0.090 |
Why?
|
| Mice | 6 | 2024 | 81533 | 0.090 |
Why?
|
| Neutrophils | 1 | 2021 | 3767 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 22172 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4369 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2019 | 18965 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 2201 | 0.070 |
Why?
|
| Macrophages | 1 | 2021 | 5769 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3466 | 0.060 |
Why?
|
| Humans | 10 | 2024 | 761572 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18253 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 11904 | 0.040 |
Why?
|
| Bronchoconstriction | 1 | 2019 | 142 | 0.040 |
Why?
|
| Biomass | 1 | 2018 | 137 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2020 | 526 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2019 | 221 | 0.040 |
Why?
|
| Smoke | 1 | 2018 | 235 | 0.030 |
Why?
|
| Male | 4 | 2024 | 360842 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 699 | 0.030 |
Why?
|
| Female | 3 | 2024 | 392686 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1486 | 0.030 |
Why?
|
| Piperidines | 1 | 2019 | 1656 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 3713 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5205 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3162 | 0.020 |
Why?
|
| Developing Countries | 1 | 2018 | 2885 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5869 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14416 | 0.010 |
Why?
|
| Pneumonia | 1 | 2015 | 2143 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11530 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74213 | 0.010 |
Why?
|